retatrutide and tirzepatide taken together Retatrutide, an experimental weight-loss drug, has not been approved by Comparing the Big 3, Semaglutide,

Abstract Aims/hypothesis Whether sodiumglucose co-transporter 2 inhibitors (SGLT2is) or glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are cost-effective based solely on their cardiovascular and kidney benefits is unknown

When calculating cost per percentage point of weight loss, the 4mg dose often emerges as the most economically efficient tier

Both are FDA-approved GLP-1 medications that regulate appetite

Dizziness, headaches, and other neurological symptoms may occur

The SLC25 family of proteins are mitochondrial carriers essential for the functioning of eukaryotes because they transport nutrients such as amino acids, carboxylic acids, fatty acids, cofactors, inorganic ions, and nucleotides across the mitochondria inner membrane for energy conversion and maintenance of the cell 34

Thyroid function: To rule out thyroid conditions that affect weight and metabolism